New Insights from Studies of Clonal Hematopoiesis
Top Cited Papers
Open Access
- 1 October 2018
- journal article
- review article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 24 (19), 4633-4642
- https://doi.org/10.1158/1078-0432.ccr-17-3044
Abstract
Clonal hematopoiesis (CH) describes an asymptomatic expansion of blood cells descended from a single hematopoietic stem cell. Recent studies have shown that CH increases in frequency with aging, and is often driven by somatic mutations in genes that are recurrently mutated in hematologic malignancies. When CH is associated with a mutation in a leukemia-associated gene at a variant allele frequency of 0.02 or greater, it is termed "clonal hematopoiesis of indeterminate potential" (CHIP). CHIP has a 0.5-1% risk per year of progression to hematological neoplasia, and increases both all-cause mortality and the risk of myocardial infarction and ischemic stroke due to a pro-inflammatory interaction between clonally-derived leukocytes and vascular endothelium. CH frequently emerges in the context of immune-mediated marrow failure syndromes such as aplastic anemia, while CH emerging after cytotoxic cancer therapy is strongly associated with subsequent development of a therapy-related myeloid neoplasm, especially if a TP53 mutation is present. However, risk factors for developing CH other than aging, marrow failure, and cytotoxic radiotherapy or chemotherapy are poorly defined. In this review, we discuss the epidemiology, molecular mechanisms, and clinical consequences of this common and clinically important biological state.Keywords
This publication has 54 references indexed in Scilit:
- Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesisNature Genetics, 2012
- The Origin and Evolution of Mutations in Acute Myeloid LeukemiaCell, 2012
- Detectable clonal mosaicism from birth to old age and its relationship to cancerNature Genetics, 2012
- Detectable clonal mosaicism and its relationship to aging and cancerNature Genetics, 2012
- Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid LeukemiaThe New England Journal of Medicine, 2012
- TET2andDNMT3AMutations in Human T-Cell LymphomaThe New England Journal of Medicine, 2012
- Dnmt3a is essential for hematopoietic stem cell differentiationNature Genetics, 2011
- Protective and pathogenic functions of macrophage subsetsNature Reviews Immunology, 2011
- Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2Nature, 2010
- A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia veraNature, 2005